Payment overview · 2025
General Payments
$500.90
24 reported records · 15 companies
Healthcare provider profile · identity verified
Mark A Martindale, M.D.
Allopathic & Osteopathic Physicians|Internal Medicine · BENTON, AR · NPI 1205911849
Verified facts
What the public records show
CMS Open Payments records show Mark A Martindale, M.D. received $500.90 in general payments during 2025 across 24 reported records.
Dexcom, Inc. accounted for 13.4% of that reported general-payment amount.
The Open Payments records used for this analysis explicitly named 20 associated products.
PFIZER INC. reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported ELIQUIS as an associated drug or biological on 87112 records involving 36032 distinct recipient NPIs. Public Medicare Part D data also shows 89 claims for Eliquis by this doctor in 2024.
These records do not establish that a payment influenced prescribing or medical care.
Separate record types
Research & Ownership
Research Payments (direct recipient): not present in the loaded data
Associated Research Funding (for example, named PI): not present in the loaded data
Ownership / Investment: not present in the loaded data
These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.
Who paid this doctor?
Companies in 2025 General Payments
| Reported company | Canonical company | Amount | Share | Records | Year |
|---|---|---|---|---|---|
| Dexcom, Inc. | Unresolved — no canonical attribution shown | $67.22 | 13.4% | 4 | 2025 |
| Sequel Med Tech, LLC | Unresolved — no canonical attribution shown | $66.79 | 13.3% | 2 | 2025 |
| SANOFI PASTEUR INC. | Unresolved — no canonical attribution shown | $46.26 | 9.2% | 2 | 2025 |
| Amgen Inc. | Unresolved — no canonical attribution shown | $45.72 | 9.1% | 3 | 2025 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | Unresolved — no canonical attribution shown | $38.59 | 7.7% | 2 | 2025 |
| Medtronic, Inc. |
Medtronic, Inc. exact · evidence 2025-07-22 |
$33.15 | 6.6% | 2 | 2025 |
| VERTEX PHARMACEUTICALS INCORPORATED | Unresolved — no canonical attribution shown | $29.57 | 5.9% | 1 | 2025 |
| Insulet Corporation | Unresolved — no canonical attribution shown | $28.30 | 5.7% | 1 | 2025 |
| Vanda Pharmaceuticals Inc. | Unresolved — no canonical attribution shown | $25.54 | 5.1% | 1 | 2025 |
| Xeris Pharmaceuticals, Inc. | Unresolved — no canonical attribution shown | $24.33 | 4.9% | 1 | 2025 |
| Seqirus USA Inc | Unresolved — no canonical attribution shown | $23.16 | 4.6% | 1 | 2025 |
| Lundbeck LLC | Unresolved — no canonical attribution shown | $20.28 | 4.0% | 1 | 2025 |
| Solventum Corporation | Unresolved — no canonical attribution shown | $18.48 | 3.7% | 1 | 2025 |
| PFIZER INC. | Unresolved — no canonical attribution shown | $18.03 | 3.6% | 1 | 2025 |
| Phathom Pharmaceuticals, Inc. | Unresolved — no canonical attribution shown | $15.48 | 3.1% | 1 | 2025 |
What were the payments for?
Payment categories
| Category | Amount | Records |
|---|---|---|
| Food and Beverage | $500.90 | 24 |
A meal, consulting fee, royalty, and travel payment describe different kinds of reported relationships and should not be interpreted as equivalent.
Analysis 1 · Payment-linked products
Products named in Open Payments records
| Reported product | Type | Reported company | Related amount* | Records | Year |
|---|---|---|---|---|---|
| Dexcom G6 Transmitter Normalized: dexcom g6 transmitter |
Medical Supply | Dexcom, Inc. | $67.22 | 4 | 2025 |
Source payment records
|
|||||
| TWIIST Normalized: twiist |
Device | Sequel Med Tech, LLC | $66.79 | 2 | 2025 |
Source payment records
|
|||||
| BEYFORTUS Normalized: beyfortus |
Biological | SANOFI PASTEUR INC. | $46.26 | 2 | 2025 |
Source payment records
|
|||||
| REPATHA Normalized: repatha |
Biological | Amgen Inc. | $45.72 | 3 | 2025 |
Source payment records
|
|||||
| CAPLYTA Normalized: caplyta |
Drug | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $38.59 | 2 | 2025 |
Source payment records
|
|||||
| MINIMED 780G Normalized: minimed 780g |
Device | Medtronic, Inc. | $33.15 | 2 | 2025 |
Source payment records
|
|||||
| JOURNAVX Normalized: journavx |
Drug | VERTEX PHARMACEUTICALS INCORPORATED | $29.57 | 1 | 2025 |
Source payment records
|
|||||
| OTEZLA Normalized: otezla |
Drug | Amgen Inc. | $29.12 | 2 | 2025 |
Source payment records
|
|||||
| Omnipod Normalized: omnipod |
Device | Insulet Corporation | $28.30 | 1 | 2025 |
Source payment records
|
|||||
| FANAPT Normalized: fanapt |
Drug | Vanda Pharmaceuticals Inc. | $25.54 | 1 | 2025 |
Source payment records
|
|||||
| GVOKE HYPOPEN Normalized: gvoke hypopen |
Drug | Xeris Pharmaceuticals, Inc. | $24.33 | 1 | 2025 |
Source payment records
|
|||||
| Flucelvax Normalized: flucelvax |
Biological | Seqirus USA Inc | $23.16 | 1 | 2025 |
Source payment records
|
|||||
| FLUZONE HIGH-DOSE Normalized: fluzone high dose |
Biological | SANOFI PASTEUR INC. | $23.02 | 1 | 2025 |
Source payment records
|
|||||
| VYEPTI Normalized: vyepti |
Biological | Lundbeck LLC | $20.28 | 1 | 2025 |
Source payment records
|
|||||
| ACTIV.A.C. Normalized: activ a c |
Device | Solventum Corporation | $18.48 | 1 | 2025 |
Source payment records
|
|||||
| V.A.C. VERAFLO Normalized: v a c veraflo |
Device | Solventum Corporation | $18.48 | 1 | 2025 |
Source payment records
|
|||||
| V.A.C.ULTA Normalized: v a c ulta |
Device | Solventum Corporation | $18.48 | 1 | 2025 |
Source payment records
|
|||||
| NURTEC ODT Normalized: nurtec odt |
Drug | PFIZER INC. | $18.03 | 1 | 2025 |
Source payment records
|
|||||
| ZAVZPRET Normalized: zavzpret |
Drug | PFIZER INC. | $18.03 | 1 | 2025 |
Source payment records
|
|||||
| VOQUEZNA Normalized: voquezna |
Drug | Phathom Pharmaceuticals, Inc. | $15.48 | 1 | 2025 |
Source payment records
|
|||||
* Product-associated amounts are non-additive because one payment record may name more than one product.
These products were named on specific Open Payments records. A named product does not show that the payment influenced treatment or prescribing.
Public prescribing for products named in payments
No exact normalized or approved-alias overlap was found in the loaded Part D year. This does not mean the doctor never prescribed the product.
The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.
Analysis 2 · Same-company prescribing overlap
Drugs reported in other payments from the same company that also appear in Medicare Part D
This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.
| Paying company | Payment year | Drug reported by same entity | Open Payments evidence | Part D | Claims | Beneficiaries |
|---|---|---|---|---|---|---|
| PFIZER INC. Exact reporting entity; no affiliate inference |
2025 | ELIQUIS open payments reported associated product |
CMS Open Payments — General Payments 87112 supporting records · 36032 recipient NPIs · example record 1228794063 |
Eliquis · 2024 Exact normalized brand match · 1 Part D row |
89 | 24 |
These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.
Public Medicare Part D data
Provider-and-drug rows loaded for 2024
| Brand | Generic | Claims | Beneficiaries |
|---|---|---|---|
| Levothyroxine Sodium | Levothyroxine Sodium | 439 | 95 |
| Atorvastatin Calcium | Atorvastatin Calcium | 400 | 94 |
| Gabapentin | Gabapentin | 361 | 73 |
| Amlodipine Besylate | Amlodipine Besylate | 360 | 79 |
| Pantoprazole Sodium | Pantoprazole Sodium | 323 | 72 |
| Metoprolol Succinate | Metoprolol Succinate | 261 | 52 |
| Hydrocodone-Acetaminophen | Hydrocodone/Acetaminophen | 258 | 54 |
| Furosemide | Furosemide | 252 | 64 |
| Alprazolam | Alprazolam | 248 | 35 |
| Omeprazole | Omeprazole | 234 | 55 |
| Lisinopril | Lisinopril | 232 | 53 |
| Potassium Chloride | Potassium Chloride | 223 | 51 |
| Losartan Potassium | Losartan Potassium | 211 | 43 |
| Clopidogrel | Clopidogrel Bisulfate | 204 | 49 |
| Prednisone | Prednisone | 192 | 87 |
| Allopurinol | Allopurinol | 179 | 38 |
| Sertraline Hcl | Sertraline Hcl | 179 | 31 |
| Rosuvastatin Calcium | Rosuvastatin Calcium | 174 | 42 |
| Hydrochlorothiazide | Hydrochlorothiazide | 169 | 42 |
| Simvastatin | Simvastatin | 163 | 35 |
| Meloxicam | Meloxicam | 157 | 41 |
| Metformin Hcl | Metformin Hcl | 157 | 43 |
| Lorazepam | Lorazepam | 149 | 24 |
| Fluoxetine Hcl | Fluoxetine Hcl | 146 | 28 |
| Metoprolol Tartrate | Metoprolol Tartrate | 141 | 41 |
| Tramadol Hcl | Tramadol Hcl | 135 | 30 |
| Trazodone Hcl | Trazodone Hcl | 133 | 26 |
| Zolpidem Tartrate | Zolpidem Tartrate | 129 | 19 |
| Albuterol Sulfate Hfa | Albuterol Sulfate | 127 | 33 |
| Azithromycin | Azithromycin | 124 | 98 |
| Tamsulosin Hcl | Tamsulosin Hcl | 122 | 33 |
| Clonazepam | Clonazepam | 109 | 15 |
| Escitalopram Oxalate | Escitalopram Oxalate | 102 | 29 |
| Duloxetine Hcl | Duloxetine Hcl | 96 | 25 |
| Carvedilol | Carvedilol | 93 | 23 |
| Oxycodone-Acetaminophen | Oxycodone Hcl/Acetaminophen | 92 | 22 |
| Celecoxib | Celecoxib | 91 | 23 |
| Jardiance | Empagliflozin | 90 | 13 |
| Eliquis | Apixaban | 89 | 24 |
| Cefdinir | Cefdinir | 88 | 60 |
| Cephalexin | Cephalexin | 85 | 49 |
| Ozempic | Semaglutide | 84 | 13 |
| Spironolactone | Spironolactone | 84 | 23 |
| Triamterene-Hydrochlorothiazid | Triamterene/Hydrochlorothiazid | 82 | 17 |
| Pravastatin Sodium | Pravastatin Sodium | 79 | 17 |
| Atenolol | Atenolol | 78 | 16 |
| Losartan-Hydrochlorothiazide | Losartan/Hydrochlorothiazide | 78 | 18 |
| Donepezil Hcl | Donepezil Hcl | 76 | 18 |
| Fluconazole | Fluconazole | 71 | 36 |
| Warfarin Sodium | Warfarin Sodium | 68 | 12 |
| Farxiga | Dapagliflozin Propanediol | 67 | suppressed |
| Propranolol Hcl | Propranolol Hcl | 67 | 12 |
| Alendronate Sodium | Alendronate Sodium | 66 | 20 |
| Diazepam | Diazepam | 64 | suppressed |
| Esomeprazole Magnesium | Esomeprazole Magnesium | 63 | 16 |
| Nitrofurantoin Mono-Macro | Nitrofurantoin Monohyd/M-Cryst | 63 | 43 |
| Lisinopril-Hydrochlorothiazide | Lisinopril/Hydrochlorothiazide | 62 | 14 |
| Omnipod 5 Dexg7g6 Pods (Gen 5) | Insulin Pump Cart,auto,bt,g6/7 | 62 | 12 |
| Levofloxacin | Levofloxacin | 60 | 40 |
| Buspirone Hcl | Buspirone Hcl | 59 | 11 |
| Diclofenac Sodium | Diclofenac Sodium | 59 | 19 |
| Glipizide Er | Glipizide | 54 | 16 |
| Paroxetine Hcl | Paroxetine Hcl | 54 | 11 |
| Tizanidine Hcl | Tizanidine Hcl | 54 | 16 |
| Memantine Hcl | Memantine Hcl | 52 | suppressed |
| Nebivolol Hcl | Nebivolol Hcl | 52 | suppressed |
| Xarelto | Rivaroxaban | 52 | 14 |
| Lansoprazole | Lansoprazole | 51 | suppressed |
| Trelegy Ellipta | Fluticasone/Umeclidin/Vilanter | 51 | suppressed |
| Cyclobenzaprine Hcl | Cyclobenzaprine Hcl | 50 | 18 |
| Bumetanide | Bumetanide | 49 | 13 |
| Levetiracetam | Levetiracetam | 49 | suppressed |
| Famotidine | Famotidine | 48 | suppressed |
| Venlafaxine Hcl Er | Venlafaxine Hcl | 48 | 11 |
| Bupropion Xl | Bupropion Hcl | 46 | suppressed |
| Ondansetron Odt | Ondansetron | 46 | 19 |
| Fluticasone Propionate | Fluticasone Propionate | 45 | 14 |
| Amitriptyline Hcl | Amitriptyline Hcl | 44 | suppressed |
| Doxycycline Hyclate | Doxycycline Hyclate | 44 | 42 |
| Meclizine Hcl | Meclizine Hcl | 44 | suppressed |
| Metformin Hcl Er | Metformin Hcl | 44 | 13 |
| Montelukast Sodium | Montelukast Sodium | 44 | 12 |
| Ropinirole Hcl | Ropinirole Hcl | 44 | suppressed |
| Mirtazapine | Mirtazapine | 43 | suppressed |
| Ciprofloxacin Hcl | Ciprofloxacin Hcl | 42 | 32 |
| Stiolto Respimat | Tiotropium Br/Olodaterol Hcl | 42 | suppressed |
| Pregabalin | Pregabalin | 41 | suppressed |
| Tresiba Flextouch U-100 | Insulin Degludec | 41 | suppressed |
| Baclofen | Baclofen | 40 | suppressed |
| Fludrocortisone Acetate | Fludrocortisone Acetate | 38 | suppressed |
| Isosorbide Mononitrate Er | Isosorbide Mononitrate | 38 | suppressed |
| Lantus Solostar | Insulin Glargine,hum.Rec.Anlog | 38 | 13 |
| Amoxicillin-Clavulanate Potass | Amoxicillin/Potassium Clav | 37 | 31 |
| Testosterone Cypionate | Testosterone Cypionate | 36 | suppressed |
| Estradiol | Estradiol | 35 | suppressed |
| Sulfamethoxazole-Trimethoprim | Sulfamethoxazole/Trimethoprim | 35 | 21 |
| Acetaminophen-Codeine | Acetaminophen With Codeine | 34 | suppressed |
| Diphenoxylate-Atropine | Diphenoxylate Hcl/Atropine | 34 | suppressed |
| Olmesartan Medoxomil | Olmesartan Medoxomil | 33 | suppressed |
| Olmesartan-Hydrochlorothiazide | Olmesartan/Hydrochlorothiazide | 33 | suppressed |
| Clonidine Hcl | Clonidine Hcl | 32 | 12 |
| Valsartan | Valsartan | 32 | suppressed |
| Glipizide | Glipizide | 31 | suppressed |
| Insulin Lispro | Insulin Lispro | 31 | suppressed |
| Nitroglycerin | Nitroglycerin | 31 | 13 |
| Nystatin | Nystatin | 31 | 16 |
| Primidone | Primidone | 31 | suppressed |
| Promethazine Hcl | Promethazine Hcl | 31 | suppressed |
| Cyanocobalamin Injection | Cyanocobalamin (Vitamin B-12) | 30 | suppressed |
| Ezetimibe | Ezetimibe | 30 | suppressed |
| Sucralfate | Sucralfate | 29 | 13 |
| Temazepam | Temazepam | 29 | suppressed |
| Citalopram Hbr | Citalopram Hydrobromide | 28 | suppressed |
| Doxycycline Monohydrate | Doxycycline Monohydrate | 28 | 21 |
| Eszopiclone | Eszopiclone | 28 | suppressed |
| Quetiapine Fumarate | Quetiapine Fumarate | 28 | suppressed |
| Symbicort | Budesonide/Formoterol Fumarate | 28 | suppressed |
| Synthroid | Levothyroxine Sodium | 28 | suppressed |
| Amiodarone Hcl | Amiodarone Hcl | 27 | suppressed |
| Carbidopa-Levodopa | Carbidopa/Levodopa | 27 | suppressed |
| Hydrocortisone | Hydrocortisone | 27 | suppressed |
| Oxybutynin Chloride | Oxybutynin Chloride | 27 | suppressed |
| Vraylar | Cariprazine Hcl | 27 | suppressed |
| Hydroxychloroquine Sulfate | Hydroxychloroquine Sulfate | 26 | suppressed |
| Anoro Ellipta | Umeclidinium Brm/Vilanterol Tr | 25 | suppressed |
| Desvenlafaxine Succinate Er | Desvenlafaxine Succinate | 25 | suppressed |
| Aimovig Autoinjector | Erenumab-Aooe | 24 | suppressed |
| Glimepiride | Glimepiride | 24 | suppressed |
| Mounjaro | Tirzepatide | 24 | suppressed |
| Oxycodone Hcl | Oxycodone Hcl | 23 | suppressed |
| Phenytoin Sodium Extended | Phenytoin Sodium Extended | 23 | suppressed |
| Shingrix | Varicella-Zoster Ge/As01b/Pf | 23 | 17 |
| Valproic Acid | Valproic Acid (As Sodium Salt) | 23 | suppressed |
| Carbamazepine | Carbamazepine | 22 | suppressed |
| Colestipol Hcl | Colestipol Hcl | 21 | suppressed |
| Myrbetriq | Mirabegron | 21 | suppressed |
| Forteo | Teriparatide | 20 | suppressed |
| Repatha Sureclick | Evolocumab | 20 | suppressed |
| Toujeo Solostar | Insulin Glargine,hum.Rec.Anlog | 20 | suppressed |
| Aripiprazole | Aripiprazole | 19 | suppressed |
| Fenofibrate | Fenofibrate | 19 | suppressed |
| Ramipril | Ramipril | 19 | suppressed |
| Valacyclovir | Valacyclovir Hcl | 19 | suppressed |
| Ventolin Hfa | Albuterol Sulfate | 19 | suppressed |
| Amlodipine Besylate-Benazepril | Amlodipine Besylate/Benazepril | 18 | suppressed |
| Novolog | Insulin Aspart | 18 | suppressed |
| Ondansetron Hcl | Ondansetron Hcl | 18 | suppressed |
| Benztropine Mesylate | Benztropine Mesylate | 17 | suppressed |
| Colchicine | Colchicine | 17 | suppressed |
| Humalog | Insulin Lispro | 17 | suppressed |
| Incruse Ellipta | Umeclidinium Bromide | 17 | suppressed |
| Naproxen | Naproxen | 17 | suppressed |
| Novolog Flexpen | Insulin Aspart | 17 | suppressed |
| Rybelsus | Semaglutide | 17 | suppressed |
| Soliqua 100-33 | Insulin Glargine/Lixisenatide | 17 | suppressed |
| Sumatriptan Succinate | Sumatriptan Succinate | 17 | suppressed |
| Trulicity | Dulaglutide | 17 | suppressed |
| Chlorthalidone | Chlorthalidone | 16 | suppressed |
| Entresto | Sacubitril/Valsartan | 16 | suppressed |
| Metronidazole | Metronidazole | 16 | suppressed |
| Pioglitazone Hcl | Pioglitazone Hcl | 16 | suppressed |
| Toujeo Max Solostar | Insulin Glargine,hum.Rec.Anlog | 16 | suppressed |
| Amoxicillin | Amoxicillin | 15 | 14 |
| Arexvy | Rsvpref3 Antigen/As01e/Pf | 15 | 15 |
| Diltiazem 24hr Er (Cd) | Diltiazem Hcl | 15 | suppressed |
| Finasteride | Finasteride | 15 | suppressed |
| Zonisamide | Zonisamide | 15 | suppressed |
| Irbesartan | Irbesartan | 14 | suppressed |
| Lactulose | Lactulose | 14 | suppressed |
| Latanoprost | Latanoprost | 14 | suppressed |
| Methotrexate | Methotrexate Sodium | 14 | suppressed |
| Vitamin D2 | Ergocalciferol (Vitamin D2) | 14 | suppressed |
| Digoxin | Digoxin | 13 | suppressed |
| Pindolol | Pindolol | 13 | suppressed |
| Rizatriptan | Rizatriptan Benzoate | 13 | suppressed |
| Terazosin Hcl | Terazosin Hcl | 13 | suppressed |
| Aspirin-Dipyridamole Er | Aspirin/Dipyridamole | 12 | suppressed |
| Breztri Aerosphere | Budesonide/Glycopyr/Formoterol | 12 | suppressed |
| Carisoprodol | Carisoprodol | 12 | suppressed |
| Divalproex Sodium | Divalproex Sodium | 12 | suppressed |
| Emgality Pen | Galcanezumab-Gnlm | 12 | suppressed |
| Fenofibrate | Fenofibrate Nanocrystallized | 12 | suppressed |
| Fluticasone-Salmeterol | Fluticasone Propion/Salmeterol | 12 | suppressed |
| Indomethacin | Indomethacin | 12 | suppressed |
| Lacosamide | Lacosamide | 12 | suppressed |
| Risperidone | Risperidone | 12 | suppressed |
| Spiriva Handihaler | Tiotropium Bromide | 12 | suppressed |
| Topiramate | Topiramate | 12 | suppressed |
| Verapamil Er | Verapamil Hcl | 12 | suppressed |
| Breo Ellipta | Fluticasone/Vilanterol | 11 | suppressed |
| Divalproex Sodium Er | Divalproex Sodium | 11 | suppressed |
| Gemfibrozil | Gemfibrozil | 11 | suppressed |
| Imipramine Hcl | Imipramine Hcl | 11 | suppressed |
| Lamotrigine | Lamotrigine | 11 | suppressed |
| Lubiprostone | Lubiprostone | 11 | suppressed |
| Repatha Syringe | Evolocumab | 11 | suppressed |
Timeline
Payment and prescribing data by year
Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.
| Year | General Payments | Main payer | Explicit products | Company overlaps | Part D coverage |
|---|---|---|---|---|---|
| 2025 | $500.90 · 24 records | Dexcom, Inc. | ACTIV.A.C., BEYFORTUS, CAPLYTA, Dexcom G6 Transmitter, FANAPT, FLUZONE HIGH-DOSE, Flucelvax, GVOKE HYPOPEN, JOURNAVX, MINIMED 780G, NURTEC ODT, OTEZLA, Omnipod, REPATHA, TWIIST, V.A.C. VERAFLO, V.A.C.ULTA, VOQUEZNA, VYEPTI, ZAVZPRET | 1 | — |
| 2024 | — | — | — | — | Complete |
Questions to ask
Questions you could discuss with your doctor
- How do you evaluate evidence when you have a financial relationship with PFIZER INC.?
- Are there reasonable alternatives I should understand when we discuss treatment options?
- How should I interpret the industry-payment records shown here in the context of my care?
These are general questions generated from reviewed templates. They are not personalized medical advice.
Sources and limitations
How to read this page
- Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
- Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
- Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
- Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
- When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.
Loaded source releases
| Dataset | Year | Publication | Source |
|---|---|---|---|
| CMS Open Payments — General Payments | 2025 | 2026-06-30 | Original source |
| Medicare Part D Prescribers by Provider and Drug | 2024 | 2026-05-06 | Original source |
| NPPES Data Dissemination V2 | current / reference data | 2026-08-10 | Original source |
Full methodology · Questions & answers · Report a possible error